Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1980 Oct 11;281(6246):973–974. doi: 10.1136/bmj.281.6246.973

Effect of treatment of hyperlipidaemia on haemostatic variables.

R S Elkeles, R Chakrabarti, M Vickers, Y Stirling, T W Meade
PMCID: PMC1714356  PMID: 7427547

Abstract

The haemostatic function of 11 men with hyperlipidaemia was measured before and after they were treated with a carbohydrate-reduced, fat-modified diet. After treatment, which significantly reduced serum triglyceride and cholesterol concentrations, they showed a significant fall in mean levels of clotting factors VII, VIII, and X and a rise in fibrinolytic activity. These findings suggest that haemostatic function may be important in the pathogenesis of ischaemic heart disease.

Full text

PDF
973

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlson L. A., Böttiger L. E., Ahfeldt P. E. Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol. Acta Med Scand. 1979;206(5):351–360. [PubMed] [Google Scholar]
  2. Ciświcka-Sznajderman M., Berent H., Rymaszewski Z. The effect of combined treatment with phenformin and stanazolol on blood lipids and fibrinolytic activity in patients with hypertriglyceridaemia. Atherosclerosis. 1974 Jan-Feb;19(1):153–159. doi: 10.1016/0021-9150(74)90051-3. [DOI] [PubMed] [Google Scholar]
  3. Elkeles R. S. Effect of treatment of hypertriglyceridaemia on high and low density lipoprotein cholesterol concentrations. Lancet. 1979 May 5;1(8123):980–981. doi: 10.1016/s0140-6736(79)91760-4. [DOI] [PubMed] [Google Scholar]
  4. Kannel W. B., Castelli W. P., Gordon T., McNamara P. M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med. 1971 Jan;74(1):1–12. doi: 10.7326/0003-4819-74-1-1. [DOI] [PubMed] [Google Scholar]
  5. Meade T. W., Brozović M., Chakrabarth R., Howarth D. J., North W. R., Stirling Y. An epidemiological study of the haemostatic and other effects of oral contraceptives. Br J Haematol. 1976 Nov;34(3):353–364. doi: 10.1111/j.1365-2141.1976.tb03582.x. [DOI] [PubMed] [Google Scholar]
  6. Meade T. W., North W. R., Chakrabarti R., Haines A. P., Stirling Y. Population-based distributions of haemostatic variables. Br Med Bull. 1977 Sep;33(3):283–288. doi: 10.1093/oxfordjournals.bmb.a071448. [DOI] [PubMed] [Google Scholar]
  7. Meade T. W., North W. R., Chakrabarti R., Stirling Y., Haines A. P., Thompson S. G., Brozovié M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980 May 17;1(8177):1050–1054. doi: 10.1016/s0140-6736(80)91498-1. [DOI] [PubMed] [Google Scholar]
  8. Pelkonen R., Nikkilä E. A., Koskinen S., Penttinen K., Sarna S. Association of serum lipids and obesity with cardiovascular mortality. Br Med J. 1977 Nov 5;2(6096):1185–1187. doi: 10.1136/bmj.2.6096.1185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Tabaqchali S., Chait A., Harrison R., Lewis B. Experience with simplified scheme of treatment of hyperlipidaemia. Br Med J. 1974 Aug 10;3(5927):377–380. doi: 10.1136/bmj.3.5927.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wilhelmsen L., Wedel H., Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation. 1973 Nov;48(5):950–958. doi: 10.1161/01.cir.48.5.950. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES